{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T14:43:16Z","timestamp":1773153796488,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[1998,4,1]],"date-time":"1998-04-01T00:00:00Z","timestamp":891388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[1998,4]]},"DOI":"10.1016\/s0006-2952(97)00615-1","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T11:22:27Z","timestamp":1027596147000},"page":"1229-1234","source":"Crossref","is-referenced-by-count":23,"title":["Vincristine Saturation of Cellular Binding Sites and Its Cytotoxic Activity in Human Lymphoblastic Leukemia Cells"],"prefix":"10.1016","volume":"55","author":[{"given":"Hiroyuki","family":"Kobayashi","sequence":"first","affiliation":[]},{"given":"Yuzuru","family":"Takemura","sequence":"additional","affiliation":[]},{"given":"James F.","family":"Holland","sequence":"additional","affiliation":[]},{"given":"Takao","family":"Ohnuma","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0006-2952(97)00615-1_BIB1","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/bjc.1986.192","article-title":"Effects of cell density on drug-induced cell kill kinetics in vitro (inoculum effect)","volume":"54","author":"Ohnuma","year":"1986","journal-title":"Br J Cancer"},{"key":"10.1016\/S0006-2952(97)00615-1_BIB2","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/BF00685154","article-title":"Miyachi H, Hayashi K, Sekiguchi S and Ohnuma T, The influence of tumor cell density on cellular accumulation of doxorubicin or cisplatin in vitro","volume":"27","author":"Takemura","year":"1991","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/S0006-2952(97)00615-1_BIB3","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/BF00695987","article-title":"Relationship between tumor cell density and drug concentration and the cytotoxic effects of doxorubicin or vincristine","volume":"31","author":"Kobayashi","year":"1992","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/S0006-2952(97)00615-1_BIB4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF01641616","article-title":"Comparative antibacterial activity of azlocillin, mezlocillin, carbenicillin and ticarcillin and relative stability to beta-lactamases of Pseudomonas aeruginosa and Klebsiella aerogenes","volume":"7","author":"Basker","year":"1979","journal-title":"Infection"},{"key":"10.1016\/S0006-2952(97)00615-1_BIB5","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1128\/AAC.11.1.74","article-title":"Mezlocillin","volume":"11","author":"Bodey","year":"1977","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/S0006-2952(97)00615-1_BIB6","first-page":"891","article-title":"Rosette-forming human lymphoid cell lines","volume":"49","author":"Minowada","year":"1972","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/S0006-2952(97)00615-1_BIB7","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/bjc.1982.215","article-title":"Vindesine receptors in cells of a human leukaemia cell line","volume":"46","author":"Totsuka","year":"1982","journal-title":"Br J Cancer"},{"key":"10.1016\/S0006-2952(97)00615-1_BIB8","unstructured":"Harlow E and Lane D, Preparing total cell lysates for immunoblotting. Antibodies. A Laboratory Manual, pp. 481\u2013482. Cold Spring Harbor Laboratory Press, Plainview, NY, 1988."},{"key":"10.1016\/S0006-2952(97)00615-1_BIB9","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1093\/clinchem\/32.8.1551","article-title":"Urinary protein as measured with a pyrogallol red-molybdate complex manually and in a Hitachi 726 automated analyzer","volume":"32","author":"Watanabe","year":"1986","journal-title":"Clin Chem"},{"key":"10.1016\/S0006-2952(97)00615-1_BIB10","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0003-2697(67)90297-7","article-title":"Graphical method for the determination and presentation of binding parameters in a complex system","volume":"20","author":"Rosenthal","year":"1967","journal-title":"Anal Biochem"},{"key":"10.1016\/S0006-2952(97)00615-1_BIB11","first-page":"5480","article-title":"Differential cellular retention of vincristine and vinblastine by cultured human promyelocytic leukemia HL-60\/Cl cells","volume":"45","author":"Ferguson","year":"1985","journal-title":"Cancer Res"},{"key":"10.1016\/S0006-2952(97)00615-1_BIB12","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00686005","article-title":"Relationship between the cellular accumulation and the cytotoxicity of S12363, a new vinca alkaloid derivative","volume":"29","author":"Pierr\u00e9","year":"1992","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/S0006-2952(97)00615-1_BIB13","doi-asserted-by":"crossref","first-page":"17141","DOI":"10.1016\/S0021-9258(17)44880-0","article-title":"Binding of dolastatin 10 to tubulin at a distinct site for peptide antimitotic agents near the exchangeable nucleotide and vinca alkaloid sites","volume":"265","author":"Bai","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1016\/S0006-2952(97)00615-1_BIB14","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/0006-2952(92)90577-6","article-title":"Cellular uptake and tubulin binding properties of four Vinca alkaloids","volume":"43","author":"Singer","year":"1992","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/S0006-2952(97)00615-1_BIB15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0955-0674(92)90058-K","article-title":"Tubulin structure and biochemistry","volume":"4","author":"Luduena","year":"1992","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/S0006-2952(97)00615-1_BIB16","first-page":"1699","article-title":"Pharmacology, bio-analysis and pharmacokinetics of the vinca alkaloids and semi-synthetic derivatives (review)","volume":"12","author":"van Tellingen","year":"1992","journal-title":"Anticancer Res"},{"key":"10.1016\/S0006-2952(97)00615-1_BIB17","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0021-9681(61)90118-7","article-title":"The effect of chemotherapy on acute leukemia in the human","volume":"14","author":"Freireich","year":"1961","journal-title":"J Chronic Dis"},{"key":"10.1016\/S0006-2952(97)00615-1_BIB18","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/jps.2600761205","article-title":"Tubulin as a major determinant of tissue distribution of VCR","volume":"76","author":"Wierzba","year":"1987","journal-title":"J Pharm Sci"},{"key":"10.1016\/S0006-2952(97)00615-1_BIB19","unstructured":"Alberts DS and Chen H-SG, Tabular summary of pharmacokinetic parameters relevant to in vitro drug assay. In: Cloning of Human Tumor Stem Cells (Ed. Salmon S), pp. 351\u2013359. Alan R. Liss, New York, 1980."},{"key":"10.1016\/S0006-2952(97)00615-1_BIB20","first-page":"2603","article-title":"Pharmacokinetics of vindesine and vincristine in humans","volume":"37","author":"Owellen","year":"1977","journal-title":"Cancer Res"},{"key":"10.1016\/S0006-2952(97)00615-1_BIB21","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/mpo.2950140305","article-title":"Analysis of prognostic factors in acute lymphoblastic leukemia","volume":"14","author":"Hammond","year":"1986","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/S0006-2952(97)00615-1_BIB22","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/mpo.2950140310","article-title":"Statistical evaluation of prognostic factors in ALL and treatment results","volume":"14","author":"Sather","year":"1986","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/S0006-2952(97)00615-1_BIB23","first-page":"351","article-title":"Effects of vincristine in combination with methotrexate and other antitumor agents in human acute lymphoblastic leukemia cells in culture","volume":"48","author":"Kano","year":"1988","journal-title":"Cancer Res"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295297006151?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295297006151?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,5]],"date-time":"2021-05-05T01:50:27Z","timestamp":1620179427000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295297006151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,4]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[1998,4]]}},"alternative-id":["S0006295297006151"],"URL":"https:\/\/doi.org\/10.1016\/s0006-2952(97)00615-1","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[1998,4]]}}}